References
- Molyneux DH, Hopkins DR and Zagaria N. Disease eradication, elimination and control: The need for accurate and consistent usage. Trends Parasitol. 2004 Aug;20(8):347-51. PubMed | Google Scholar
- Fenner F. Nature, nurture and my experience with smallpox eradication. Med J Aust. 1989; 171(11-12):638-41. PubMed | Google Scholar
- Foege WH. The Global Elimination of Measles. Pub
Hlth Reports. Sept-Oct 1982; 97:402-5. PubMed | Google
Scholar
- Hopkins DR et al. The Case for Global Measles Eradication. Lancet. 1982; 319: 1396-1398. PubMed | Google Scholar
- Kofi Annan. United
Nations Foundation Board Member, calling on the W.H.O.
Executive Board to set an Eradication Date for Measles. Accessed
30 April 2017
- Whitty CJ. Milroy Lecture: Eradication of Disease: Hype, hope and reality. J Royal College Physicians. 2014 Aug;14(4):419-21. PubMed | Google Scholar
- Durrheim DN, Crowcroft NS. The price of delaying measles eradication. Lancet Public Health. 2017;2:e130-e131. PubMed | Google Scholar
- Moss WJ, Strebel P. Biological Feasibility of Measles Eradication. J Inf Dis. 2011 Jul;204 Suppl 1:S47-53. PubMed | Google Scholar
- World Health Organization. Proceedings of the Global Technical Consultation to Assess the Feasibility of Measles Eradication, 28-30 July 2010. J Infect Dis. 2011 Jul;204 Suppl 1:S4-13. PubMed | Google Scholar
- W.H.O. Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 –Summary, Conclusions and Recommendations, Weekly Epidemiological Record, 2011;86:1-16. PubMed | Google Scholar
- Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial Transmission of Measles: An Updated Review. Vaccine. 2012 Jun 8;30(27):3996-4001. PubMed | Google Scholar
- Mulholland K. Measles and Pertussis in Developing Countries with Good Vaccine Coverage. Lancet. 1995 Feb 4;345(8945):305-7. PubMed | Google Scholar
- Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: Meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78. PubMed | Google Scholar
- Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development”. Drugs RD. 2016 Dec;16(4):327-338. PubMed | Google Scholar
- Haji A et al. “Reducing routine vaccination dropout rates: Evaluating two interventions in three Kenya districts, 2014. BMC Public Health. 2016;16:152. PubMed | Google Scholar
- Eze GU, Adeleye OO. Enhancing Routine Immunization Performance using Innovative Technology in an Urban Area of Nigeria. West African Journal of Medicine. 2015;34(1):3-10. PubMed | Google Scholar
- Bangure D, Chirundu D, Gombe N et al. Effectiveness of short message services reminder on childhood immunization programme in Kadoma, Zimbabwe - a randomized controlled trial, 2013. BMC Public Health. 2015;15:137. PubMed | Google Scholar
- De Quadros CA. Can measles be eradicated globally?. Bull World Health Organ. 2004 Feb;82(2):134-8. Epub 2004 Mar 16. PubMed | Google Scholar
- Biellik R et al. First five years of experience with measles elimination in South Africa, 1996-2000”. Lancet. 2002;359:1564-1568. PubMed | Google Scholar
- Njeru I, Ajack Y, Muitherero C et al. Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? A cross-sectional study. Pan Afr Med J. 2016;24:120. PubMed | Google Scholar
- Kriss JL, Goodson J, Machekanyanga Z et al. Vaccine receipt and vaccine card availability among children of the Apostolic faith: analysis from the 2010-2011 Zimbabwe demographic and health survey. Pan Afr Med J. May 2016;24:47. PubMed | Google Scholar
- Ozawa S, Clark S, Portnoy A et al. Return on Investment from Childhood Immunization in Low- and Middle-Income Countries, 2011-20. Health Affairs. 2016 Feb;35(2):199-207. PubMed | Google Scholar
- Thompson K, Odahowski CL. The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies. Risk Analysis. 2016 Jul;36(7):1357-82. PubMed | Google Scholar
- Thompson K, Odahowski CL. Global eradication of measles: an epidemiologic and economic evaluation. J Infect Dis. 2011 Jul;204 Suppl 1:S98-106. PubMed | Google Scholar
- Baigumira JB, Levin A, Burgess C et al. Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program. J Infect Dis. 2011 Jul;204 Suppl 1:S116-23. PubMed | Google Scholar
- Progress towards regional measles elimination – worldwide, 2000-2015. Weekly Epid Rec. 2016;91:525-526. Google Scholar
- Henderson DA. Eradication: lessons from the Past. Bull World Health Organ. 1998;76 Suppl 2:17-21. PubMed | Google Scholar
- Masresha B et al. “The effect of targeted wide-age range SIAs in reducing measles incidence in the African Region.” Submitted for publication. Google Scholar
- World Health Organization. Planning and Implementing High Quality Supplemental Immunization Activities for Injectable Vaccines using the Example of Measles and Rubella Vaccines, Geneva; 2016. Google Scholar
- Gardy JL et al. Whole-genome sequencing of measles
virus genotypes H1 and D8 during outbreaks of infection following the
2010 olympic winter games reveals viral transmission routes. J Infect
Dis. 2015 Nov 15;212(10):1574-8. PubMed | Google
Scholar
- Thompson KM et al. Group Report: Developing an Eradication Investment Case, Chapter 10 in Cochi SL and Dowdle WR (eds). Disease Eradication in the 21st Century: Implications for Global Health. Cambridge, MA, MIT Press; 2011. PubMed | Google Scholar
- Mbabazi WB et al. Innovations in communication technologies for measles supplemental immunization activities: Lessons from Kenya measles vaccination campaign, November 2012. Health Policy Plan. 2015 Jun;30(5):638-44. PubMed | Google Scholar
- Kriss JL et al. Development of the World Health Organization measles assessment programmatic risk assessment tool using experience from the 2009 measles outbreak in Namibia. Risk Anal 2016; 2016 Feb 19. [Epub ahead of print]. PubMed | Google Scholar
- Sniadack DH et al. Roadmap to elimination-standard measles and rubella surveillance. Weekly Epidemiological Record. 2017 Mar 3;92(9-10):97-105. PubMed | Google Scholar
- Adhikari BB et al. Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development. Drugs RD. 2016;16:327-338. PubMed | Google Scholar
- Haji A et al. Reducing routine vaccination dropout rates: Evaluating two interventions in three Kenyan districts, 2014. BMC Public Health. 2016;16:152. PubMed | Google Scholar
- Keegan R, Dabbagh A, Strebel PM, Cochi SL. Comparing measles with previous eradication programs: enabling and constraining factors. J Infect Dis. 2011 Jul;204 Suppl 1:S54-61. PubMed | Google Scholar
- Aylward B, Hennessey KA, Zagaria N, Olivé JM, Cochi S. When is a Disease Eradicable? 100 Years of Lessons Learned. Am J Pub Hlth. 2000 Oct;90(10):1515-20. PubMed | Google Scholar
- Rota PA, Moss WJ, Takeda M et al. “Measles,” Nature Reviews: Disease Primers, 2016; 2: p. 4. Google Scholar
- Levin A, Burgess C, Garrison LP Jr et al. Global Eradication of Measles: An Epidemiologic and Economic Evaluation. J Infect Dis. 2011 Jul;204 Suppl 1:S98-106. PubMed | Google Scholar
- Cutts F, Steinglass R. Should Measles be Eradicated?. BMJ. 1998;316:765. PubMed | Google Scholar
- Thompson KM et al. Group Report: Developing an
Eradication Investment Case, Chapter 10 in Cochi SL
and Dowdle WR (eds)., Disease Eradication in the 21st Century: Implications
for Global Health.
Cambridge, MA: MIT Press: 2011. Google
Scholar
- Sniadack DH, Orenstein WA. A measles eradication goal is upon us; can rubella and congenital rubella syndrome be far behind?. Vaccine. 2013 May 31;31(24):2659-60. PubMed | Google Scholar
- Thompson KM, Odahowski CL. Systematic Review of
Health Economic Analyses of Measles and Rubella Immunization
Interventions. Risk Anal. 2016;7:1297-1314. Google
Scholar
- Strebel P. Measles. Bull World Health Org. 1998;76 Suppl 2:154-155. PubMed | Google Scholar
<